Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 500, 64-74
Abstract
No abstract availableKeywords
Funding Information
- Consejo Nacional de Investigaciones Científicas y Técnicas
- National Institutes of Health
This publication has 117 references indexed in Scilit:
- Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cellsOncogenesis, 2013
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast CancerNew England Journal of Medicine, 2012
- Maintenance of hormone responsiveness in luminal breast cancers by suppression of NotchProceedings of the National Academy of Sciences, 2011
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI: Journal of the National Cancer Institute, 2009
- The Canonical Notch Signaling Pathway: Unfolding the Activation MechanismCell, 2009
- β1 Integrin deletion from the basal compartment of the mammary epithelium affects stem cellsNature Cell Biology, 2008
- NUMB controls p53 tumour suppressor activityNature, 2008
- Pathways to tamoxifen resistanceCancer Letters, 2007
- Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitroBritish Journal of Pharmacology, 2007
- Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesisJournal of Cell Biology, 2004